TIAA CREF INVESTMENT MANAGEMENT LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 129 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$729,000
-6.8%
195,4060.0%0.00%0.0%
Q4 2018$782,000
-64.4%
195,406
-50.5%
0.00%0.0%
Q3 2018$2,194,000
+177.0%
394,644
+95.2%
0.00%0.0%
Q2 2018$792,000
-8.2%
202,165
+10.3%
0.00%0.0%
Q1 2018$863,000
+6.9%
183,275
-6.2%
0.00%0.0%
Q4 2017$807,000
-62.4%
195,382
-42.3%
0.00%0.0%
Q3 2017$2,146,000
+51.3%
338,476
+87.2%
0.00%0.0%
Q2 2017$1,418,000
-7.0%
180,825
-21.5%
0.00%0.0%
Q1 2017$1,525,000
-10.0%
230,338
-5.6%
0.00%0.0%
Q4 2016$1,694,000
-39.3%
244,039
-18.5%
0.00%
-50.0%
Q3 2016$2,792,000
-0.7%
299,578
-1.5%
0.00%0.0%
Q2 2016$2,811,000
+28.8%
304,169
+21.4%
0.00%0.0%
Q1 2016$2,182,000
+29.6%
250,4610.0%0.00%
+100.0%
Q4 2015$1,683,000
+12.0%
250,461
-3.7%
0.00%0.0%
Q3 2015$1,503,000
-34.8%
260,051
-7.9%
0.00%
-50.0%
Q2 2015$2,304,000
+29.7%
282,362
+29.7%
0.00%
+100.0%
Q1 2015$1,777,000
-11.1%
217,7350.0%0.00%0.0%
Q4 2014$1,999,000
-32.4%
217,735
-27.4%
0.00%
-50.0%
Q3 2014$2,955,000
-61.0%
300,027
-57.2%
0.00%
-60.0%
Q2 2014$7,585,000701,6340.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
CAXTON ASSOCIATES LP 784,679$643,4370.10%
Green Alpha Advisors, LLC 146,300$119,9660.08%
Virtus ETF Advisers LLC 54,106$44,3670.02%
Cedar Brook Financial Partners, LLC 104,881$86,0020.02%
PROFUND ADVISORS LLC 418,749$343,3740.02%
Arlington Capital Management, Inc. 27,735$22,7430.02%
Hennion & Walsh Asset Management, Inc. 382,158$3130.02%
Rafferty Asset Management, LLC 2,647,927$2,171,3000.02%
Brainard Capital Management LLC 16,666$13,6660.01%
Beck Bode, LLC 41,218$33,7990.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders